Statins and hip fracture risk in men: a population-based case-control study

Area of Science:

• Gerontology
• Pharmacology
• Orthopedics

Background:

• Hip fractures pose a significant health risk, especially in aging populations.
• Statins are widely prescribed cholesterol-lowering medications with potential pleiotropic effects.
• Understanding medication impacts on bone health is crucial for geriatric care.

Purpose of the Study:

• To investigate the association between hydroxymethylglutaryl-CoA inhibitor (statin) use and the risk of hip fracture in men.
• To evaluate if statin use is linked to a reduced incidence of hip fractures.

Main Methods:

• A population-based case-control study involving 6774 male hip fracture cases and 6774 matched controls.
• Data on statin dispensing were extracted from electronic pharmaceutical records from 1991 onwards.
• Analysis included matched odds ratios and confidence intervals, with adjustments for comorbidity burden.

Main Results:

• Statin use was associated with a reduced risk of hip fracture (mOR=0.81, CI=0.74-0.87).
• This association strengthened after adjusting for comorbidity burden (mOR=0.68, CI=0.62-0.74).
• The protective effect was most pronounced in men aged 80 years and older and in African Americans.

Conclusions:

• The findings suggest a potential protective role of statin use against hip fractures in men.
• These results contribute to the growing evidence of statins benefiting bone health.
• Further prospective research is recommended to confirm these findings and address potential confounding factors.